Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Influenza A virus H5N1 vaccine - NuGenerex Immuno-Oncology

Next Previous
X
Search
Drug Profile

Influenza A virus H5N1 vaccine - NuGenerex Immuno-Oncology

Alternative Names: AE 443p; AE AI vaccine; H5N1 virus vaccine - Generex Biotechnology; H5N1 virus vaccine - NuGenerex Immuno-Oncology; Influenza peptide vaccines - NuGenerex Immuno-Oncology; Pandemic influenza virus vaccine - NuGenerex Immuno-Oncology/University of Rochester

Latest Information Update: 16 Jan 2019

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Antigen Express
  • Developer NuGenerex Immuno-Oncology
  • Class Influenza A virus H5N1 vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • No development reported Influenza A virus H5N1 subtype

Most Recent Events

  • 28 Apr 2018 No recent reports of development identified for phase-I development in Influenza-A-virus-H5N1-subtype(Prevention) in Lebanon (Parenteral)
  • 28 Apr 2018 No recent reports of development identified for preclinical development in Influenza-A-virus-H5N1-subtype in USA (Parenteral)
  • 08 Feb 2017 Influenza A virus H5N1 vaccine - Antigen Express is available for licensing as of 08 Feb 2017. http://www.antigenexpress.com/ (Antigen Express pipeline, February 2017)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top